Terms: = Ovarian cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568 AND Prognosis
24 results:
1. Improving the cytotoxic response of tumor-infiltrating lymphocytes towards advanced stage ovarian cancer with an oncolytic adenovirus expressing a human vil-2 cytokine.
Quixabeira DCA; Jirovec E; Pakola S; Havunen R; Basnet S; Santos JM; Kudling TV; Clubb JHA; Haybout L; Arias V; Grönberg-Vähä-Koskela S; Cervera-Carrascon V; Pasanen A; Anttila M; Tapper J; Kanerva A; Hemminki A
Cancer Gene Ther; 2023 Nov; 30(11):1543-1553. PubMed ID: 37666898
[TBL] [Abstract] [Full Text] [Related]
2. PDP1 Promotes Cell Malignant Behavior and Is Associated with Worse Clinical Features in ovarian cancer Patients: Evidence from Bioinformatics and In Vitro Level.
Song Y; Zhang J; Zhang L; Zhang S; Shen C
Comput Math Methods Med; 2022; 2022():7397250. PubMed ID: 36276992
[TBL] [Abstract] [Full Text] [Related]
3. Exploration of the underlying biological differences and targets in ovarian cancer patients with diverse immunotherapy response.
Chen J; Chen S; Dai X; Ma L; Chen Y; Bian W; Sun Y
Front Immunol; 2022; 13():1007326. PubMed ID: 36189254
[TBL] [Abstract] [Full Text] [Related]
4. Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer.
Zou R; Jiang Q; Jin T; Chen M; Yao L; Ding H
Front Immunol; 2022; 13():956224. PubMed ID: 36032075
[TBL] [Abstract] [Full Text] [Related]
5. Proapoptotic Effect of Icariin on Human ovarian cancer Cells via the NF-[Formula: see text]B/PI3K-AKT Signaling Pathway: A Network Pharmacology-Directed Experimental Investigation.
Gao J; Fu Y; Song L; Long M; Zhang Y; Qin J; Liu H
Am J Chin Med; 2022; 50(2):589-619. PubMed ID: 35114909
[TBL] [Abstract] [Full Text] [Related]
6. Cytotoxic lymphocytes-related gene ITK from a systematic CRISPR screen could predict prognosis of ovarian cancer patients with distant metastasis.
Xu M; Huang S; Chen J; Xu W; Xiang R; Piao Y; Zhao S
J Transl Med; 2021 Oct; 19(1):447. PubMed ID: 34702300
[TBL] [Abstract] [Full Text] [Related]
7. IL-6 and IL-8 as Prognostic Factors in Peritoneal Fluid of ovarian cancer.
Rodrigues ISS; Martins-Filho A; Micheli DC; Lima CA; Tavares-Murta BM; Murta EFC; Nomelini RS
Immunol Invest; 2020 Jul; 49(5):510-521. PubMed ID: 31755326
[TBL] [Abstract] [Full Text] [Related]
8. Potential clinical application of tumor-infiltrating lymphocyte therapy for ovarian epithelial cancer prior or post-resistance to chemotherapy.
Sakellariou-Thompson D; Forget MA; Hinchcliff E; Celestino J; Hwu P; Jazaeri AA; Haymaker C; Bernatchez C
Cancer Immunol Immunother; 2019 Nov; 68(11):1747-1757. PubMed ID: 31602489
[TBL] [Abstract] [Full Text] [Related]
9. Stromal il2 is related to the neutrophil/lymphocyte ratio in epithelial ovarian cancer.
Santos TD; Jammal MP; Silveira TP; Murta EFC; Nomelini RS
Pathologica; 2019 Jun; 111(2):62-66. PubMed ID: 31388197
[TBL] [Abstract] [Full Text] [Related]
10. ΔNp73 status in peritoneal and ovarian dissemination of appendicular adenocarcinoids (goblet cells).
Prieto-Nieto MI; Pastor D; Rodríguez-Cobos J; Pérez JP; Méndez C; Palacios E; Arranz-Alvarez M; Santos-López J; Cano-Vega M; Viñal D; Rodríguez N; Domínguez G
Clin Transl Oncol; 2019 Oct; 21(10):1432-1439. PubMed ID: 31025168
[TBL] [Abstract] [Full Text] [Related]
11. Role of Intracystic Cytokines and Nitric Oxide in ovarian Neoplasms.
Martins-Filho A; Jammal MP; Micheli DC; Tavares-Murta BM; Etchebehere RM; Murta EFC; Nomelini RS
Scand J Immunol; 2017 Dec; 86(6):462-470. PubMed ID: 28960399
[TBL] [Abstract] [Full Text] [Related]
12. Effect of different anesthetic methods on cellular immune functioning and the prognosis of patients with ovarian cancer undergoing oophorectomy.
Han XR; Wen X; Li YY; Fan SH; Zhang ZF; Li H; Sun XF; Geng GQ; Sun S; Huang SQ; Wu DM; Lu J; Zheng YL
Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28935762
[TBL] [Abstract] [Full Text] [Related]
13. Serum IL-6 and IL-8 Correlate with Prognostic Factors in ovarian cancer.
Sanguinete MMM; Oliveira PH; Martins-Filho A; Micheli DC; Tavares-Murta BM; Murta EFC; Nomelini RS
Immunol Invest; 2017 Oct; 46(7):677-688. PubMed ID: 28872976
[TBL] [Abstract] [Full Text] [Related]
14. Effects of the balance between type 1 and type 2 T helper cells on ovarian cancer.
Hao CJ; Li J; Liu P; Li XL; Hu YQ; Sun JC; Wei Y
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323126
[TBL] [Abstract] [Full Text] [Related]
15. Anti-ovarian tumor response of donor peripheral blood mononuclear cells is due to infiltrating cytotoxic NK cells.
Pandey V; Oyer JL; Igarashi RY; Gitto SB; Copik AJ; Altomare DA
Oncotarget; 2016 Feb; 7(6):7318-28. PubMed ID: 26802025
[TBL] [Abstract] [Full Text] [Related]
16. Adjuvant ovarian Suppression, High-dose Chemotherapy and Immunotherapy for Premenopausal Patients with High-risk Breast cancer.
Recchia F; Candeloro G; Rosselli M; Bratta M; Pasta V; D'Orazi V; Fumagalli LA; Rea S
Anticancer Res; 2015 Dec; 35(12):6847-53. PubMed ID: 26637906
[TBL] [Abstract] [Full Text] [Related]
17. Correlation of cytokines and inducible nitric oxide synthase expression with prognostic factors in ovarian cancer.
Martins Filho A; Jammal MP; Côbo Ede C; Silveira TP; Adad SJ; Murta EF; Nomelini RS
Immunol Lett; 2014; 158(1-2):195-9. PubMed ID: 24447864
[TBL] [Abstract] [Full Text] [Related]
18. Plasma endothelial protein C receptor influences innate immune response in ovarian cancer by decreasing the population of natural killer and TH17 helper cells.
Azzazene D; Al Thawadi H; Al Farsi H; Besbes S; Geyl C; Mirshahi S; Pardo J; Faussat AM; Jeannette S; Therwath A; Pujade-Lauraine E; Mirshahi M
Int J Oncol; 2013 Oct; 43(4):1011-8. PubMed ID: 23877403
[TBL] [Abstract] [Full Text] [Related]
19. Immune response evaluation through determination of type 1, type 2, and type 17 patterns in patients with epithelial ovarian cancer.
Cândido EB; Silva LM; Carvalho AT; Lamaita RM; Filho RM; Cota BD; da Silva-Filho AL
Reprod Sci; 2013 Jul; 20(7):828-37. PubMed ID: 23239818
[TBL] [Abstract] [Full Text] [Related]
20. Correlation between DNA content, expression of Ki-67 antigen of tumor cells and immunophenotype of lymphocytes from malignant pleural effusions.
Sikora J; Dworacki G; Trybus M; Batura-Gabryel H; Zeromski J
Tumour Biol; 1998; 19(3):196-204. PubMed ID: 9591046
[TBL] [Abstract] [Full Text] [Related]
[Next]
